Madhan Jeyaraman

A Wonder Drug in the Arsenal against COVID - 19: Medication Evidence from Ivermectin

B. Suresh Kumar, Madhan Jeyaraman, Rashmi Jain & Talagavadi Channaiah Anudeep · Journal of Advances in Medicine and Medical Research · 2020

Ivermectin, an FDA approved broad-spectrum anti-parasitic agent has been recently reported to show an inhibitory activity against SARS-CoV-2 in an in-vitro study. This antiviral response has rendered it as a potential drug to be repurposed for COVID-19. Previously, ivermectin had...

Open access Research Article 10.9734/jammr/2020/v32i1030512

Surgical Management of Subtrochanteric Fracture with Intramedullary Nailing in Osteopetrosis – A Rare Case Report

Prasanna Anaberu, Deepak Kumar, Madhan Jeyaraman, Vijay Kumar & Jitesh Lamba · Asian Journal of Orthopaedic Research · 2019

Background: Osteopetrosis, also called as “Osteosclerosis”, “Marble bone disease” or “Albers-Schonberg disease, is an extremely rare inherited sclerotic bone disorder. The primary defect in osteopetrosis is due to mutation in CLCN-7 gene. Osteopetrosis is marked by increased bone...

Open access Research Article